|
End-of-day quote
Nasdaq
2026-08-19
|
5-day change | 1st Jan Change | ||
| 1.850 USD | +7.56% |
|
+9.47% | -79.51% |
| 08-11 | EnGene Therapeutics Inc. - Special Call | |
| 07-16 | EnGene Therapeutics Initiates Planned BLA Submission For Detalimogene Voraplasmid And Provides Updates On LEGEND Phase 2 Trial | CI |
Stock exchange
Quotes 5-day view: enGene Therapeutics Inc.
End-of-day quote Nasdaq| 2026-08-14 | 2026-08-17 | 2026-08-18 | 2026-08-19 | 2026-08-20 | |
|---|---|---|---|---|---|
| Last | US$1.700 | US$1.700 | US$1.720 | US$1.850 | US$1.770 |
| Volume | 919,724 | 623,324 | 690,939 | 1,263,362 | 368,436 |
| Change | +0.59% | 0.00% | +1.18% | +7.56% | -4.32% |
| Opening | US$1.690 | US$1.720 | US$1.700 | US$1.730 | US$1.840 |
| High | US$1.730 | US$1.730 | US$1.740 | US$1.895 | US$1.850 |
| Low | US$1.660 | US$1.690 | US$1.690 | US$1.730 | US$1.755 |
Performance
| 1 day | +7.56% | ||
| 1 week | +9.47% | ||
| Current month | +3.35% | ||
| 1 month | -1.07% | ||
| 3 months | +14.91% | ||
| 6 months | -82.14% | ||
| Current year | -79.51% | ||
| 1 year | -52.07% | ||
| 3 years | -83.01% |
Volumes
marketsDaily volume
1,263,362
Avg. Volume 20 sessions
704,239
Avg. Volume 20 sessions USD
1,302,842.15
Record volume 1
51,454,331
Record volume 2
24,102,681
Record volume 3
17,386,929
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
118,571,354
Net sales (USD)
0
Free-Float
99.9 %
Free-Float capitalization (USD)
118,449,091
Average Daily Capital Traded
1.1%
Indicators
Moving average 5 days
1.73
Moving average 20 days
1.77
Moving average 50 days
1.78
Moving average 100 days
3.36
Price spread / (MMA5)
-6.49%
Price spread / (MMA20)
-4.32%
Price spread / (MMA50)
-3.78%
Price spread / (MMA100)
+81.62%
STIM
RSI 9 days
61.87
RSI 14 days
53.76
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.56% | +9.47% | -52.07% | -83.01% | 119M | |
| +2.38% | +3.43% | +82.88% | +115.89% | 73.96B | |
| -0.34% | +20.82% | +53.16% | +93.42% | 64.66B | |
| -4.27% | -0.99% | -3.38% | +475.61% | 27.32B | |
| -1.97% | +20.38% | -0.37% | +0.48% | 27.86B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 25.97B | |
| -0.42% | +5.03% | +35.26% | -14.67% | 19.98B | |
| -1.79% | -4.84% | +239.54% | +414.48% | 17.84B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.24B | |
| -1.29% | +6.09% | +41.81% | +154.45% | 13.3B | |
| Average | +0.35% | +6.51% | +47.82% | +171.77% | 28.72B | |
| Weighted average by Cap. | +0.04% | +8.21% | +58.92% | +160.67% |
Historical Quotes: enGene Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 1.69 |  | 1.9 |
| 1 month | 1.66 | | 1.94 |
| Current year | 1.4 | | 12.25 |
| 1 year | 1.4 | | 12.25 |
| 3 years | 1.4 | | 47.17 |
| 5 years | 1.4 | | 47.17 |
| 10 years | 1.4 | | 47.17 |
Monthly variations
Annual variations
| 2026 | -80.40% | ||
| 2025 | +35.79% | ||
| 2024 | -27.95% | ||
| 2023 | -10.65% | ||
| 2022 | +4.77% |
- Stock Market
- Stocks
- ENGN Stock
- Quotes enGene Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
